Affected Systems |
|
|
|
|
|
growth/size/body
|
|
√
|
√
|
|
enlarged liver
|
|
|
√
|
|
enlarged spleen
|
|
√
|
√
|
|
hematopoietic system
|
√
|
√
|
√
|
|
abnormal definitive hematopoiesis
|
|
√
|
|
|
abnormal erythropoiesis
|
|
√
|
|
|
anemia
|
|
√
|
|
|
increased erythroid progenitor cell number
|
|
√
|
|
|
increased erythroblast number
|
|
√
|
|
|
decreased erythrocyte cell number
|
|
√
|
|
|
decreased hematocrit
|
|
√
|
|
|
decreased cellular hemoglobin content
|
√
|
|
|
|
decreased hemoglobin content
|
|
√
|
|
|
decreased mean corpuscular volume
|
|
√
|
|
|
abnormal lymphocyte morphology
|
|
√
|
|
|
abnormal B cell morphology
|
|
√
|
|
|
abnormal T cell morphology
|
|
√
|
|
|
abnormal spleen morphology
|
|
√
|
|
|
enlarged spleen
|
|
√
|
√
|
|
homeostasis/metabolism
|
|
|
√
|
|
homeostasis/metabolism phenotype
|
|
|
N
|
|
abnormal iron homeostasis
|
|
|
√
|
|
immune system
|
|
√
|
√
|
|
abnormal lymphocyte morphology
|
|
√
|
|
|
abnormal B cell morphology
|
|
√
|
|
|
abnormal T cell morphology
|
|
√
|
|
|
abnormal spleen morphology
|
|
√
|
|
|
enlarged spleen
|
|
√
|
√
|
|
integument
|
√
|
|
|
|
pallor
|
√
|
|
|
|
liver/biliary system
|
|
|
√
|
|
enlarged liver
|
|
|
√
|
|
liver fibrosis
|
|
|
√
|
|
cholestasis
|
|
|
√
|
|
mortality/aging
|
√
|
|
N
|
√
|
mortality/aging
|
|
|
N
|
|
prenatal lethality, complete penetrance
|
|
|
|
√
|
embryonic lethality during organogenesis, complete penetrance
|
√
|
|
|
|